Rapport Therapeutics RAPP
Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0000950170-24-093321
- Document
- 8-K
- Exhibit 99.1
- Press release
- Reports quarterly results (2.02)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Abeona Therapeutics ABEO public float $273M, Jun 30, 2025
- Ocugen OCGN public float $279M, Jun 30, 2025
- Tonix Pharmaceuticals Holding TNXP public float $271M, Jun 30, 2025
- Vanda Pharmaceuticals VNDA public float $269M, Jun 30, 2025
- Atea Pharmaceuticals AVIR public float $263M, Jun 30, 2025
